Stock Analiz

Polaryx Therapeutics, Inc. (PLYX) stock forecast and price target

Price $1.77 · data as of November 13, 2026

12-month price target

Average target$7.50
Upside / downside+323.7%
Analysts4
ConsensusStrong buy
Low $6.00Average $7.50High $10.00

Gold marker: average target · white marker: today’s price ($1.77)

Analyst ratings

Strong buy 1Buy 3Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.23—$0
Next fiscal year
ends December 31, 2027
$-0.28—$0
Next quarter
ends December 31, 2026
$-0.08—$0
Quarter after
ends March 31, 2027
$-0.07—$0

Consensus of the analysts covering Polaryx Therapeutics, updated daily.

Frequently asked questions

What is the Polaryx Therapeutics stock price target?

The average 12-month target from 4 analysts is $7.50, 323.7% above the current price of $1.77 Targets range from $6.00 to $10.00.

Is Polaryx Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Polaryx Therapeutics expected to earn?

Analysts expect EPS of $-0.23 for the fiscal year ending December 31, 2026 and $-0.28 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.